Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply...

por Auletta, Jeffery J., Novakovich, Jen L., Stritesky, Gretta L., Newman, Jeni, Fridy-Chesser, Sade T., Hailperin, Karl, Devine, Steven M.
Publicado 2021

Serum MicroRNA-155 in Acute Graft-Versus-Host-Disease (aGVHD)

por Efebera, Yvonne A, Ruppert, Amy S, Ngankeu, Apollinaire, Garman, Sabrina, Kumchala, Prasanthi, Howard, Alan, Devine, Steven M, Ranganathan, Parvathi, Garzon, Ramiro
Publicado 2019

CD103 Deficiency Prevents Graft-versus-Host Disease but Spares Graft-versus-Tumor Effects Mediated by Alloreactive CD8 T Cells

por Liu, Kechang, Anthony, Bryan A., Yearsly, Martha M., Hamadani, Mehdi, Gaughan, Alice, Wang, Jiao-Jing, Devine, Steven M., Hadley, Gregg A.
Publicado 2011

Cryopreservation of Allogeneic Hematopoietic Cell Grafts Did Not Adversely Impact Early Post-Transplant Survival during the First Six Months of the COVID-19 Pandemic

por Devine, Steven M., Kuxhausen, Michelle, Spellman, Stephen, Bupp, Caitrin, Ahn, Kwang Woo, Stefanski, Heather E., Auletta, Jeffery James, Logan, Brent, Shaw, Bronwen E.
Publicado 2022

Ongoing Risk of Unrelated Donors Testing Positive for COVID-19 Following Medical Clearance and Impact on Operations: A Report from the National Marrow Donor Program

por Stefanski, Heather E., Novakovich, Jennifer, Newman, Jennifer, Snyder, Christian, Cody, Meghann, Oakes, Jason, Nielson, Amy, Auletta, Jeffery James, Miller, John P., Devine, Steven M.
Publicado 2023

A single center’s experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation

por Haverkos, Bradley M., Huang, Ying, Elder, Patrick, O’Donnell, Lynn, Scholl, Diane, Whittaker, Becky, Vasu, Sumi, Penza, Sam, Andritsos, Leslie A., Devine, Steven M., Jaglowski, Samantha M.
Publicado 2017

Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic

por Devine, Steven M., Bo-Subait, Stephanie, Kuxhausen, Michelle, Spellman, Stephen R., Bupp, Caitrin, Ahn, Kwang Woo, Stefanski, Heather E., Auletta, Jeffery J., Logan, Brent R., Shaw, Bronwen E.
Publicado 2023

Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program

por Farhadfar, Nosha, Newman, Jeni, Novakovich, Jennifer, Barten, Jacklyn, Ndifon, Eric T., Oakes, Jason, Cody, Meghann, Pham, Huy P., Auletta, Jeffery J., Miller, John P., Devine, Steven M., Stefanski, Heather E.
Publicado 2022

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma

por Jaglowski, Samantha M., Ruppert, Amy S., Hofmeister, Craig C., Elder, Patrick, Blum, William, Klisovic, Rebecca, Vasu, Sumithira, Penza, Sam, Efebera, Yvonne A, Benson, Don M., Devine, Steven M., Andritsos, Leslie A
Publicado 2014

Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023

por Farhadfar, Nosha, Burns, Linda J., Mupfudze, Tatenda, Shaw, Bronwen E., Bollard, Catherine M., Devine, Steven M., Horowitz, Mary M., Jones, Richard J., Murthy, Hemant S., Wingard, John R., Lee, Stephanie J.
Publicado 2021

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Diseas...

por Hamadani, Mehdi, Zhang, Mei-Jie, Tang, Xiao-Ying, Fei, Mingwei, Brunstein, Claudio, Chhabra, Saurabh, D'Souza, Anita, Milano, Filippo, Phelan, Rachel, Saber, Wael, Shaw, Bronwen E., Weisdorf, Daniel, Devine, Steven M., Horowitz, Mary M.
Publicado 2020

CS1-Specific Chimeric Antigen Receptor (CAR)-Engineered Natural Killer Cells Enhance In Vitro and In Vivo Anti-tumor Activity Against Human Multiple Myeloma

por Chu, Jianhong, Deng, Youcai, Benson, Don M., He, Shun, Hughes, Tiffany, Zhang, Jianying, Peng, Yong, Mao, Hsiaoyin, Yi, Ling, Ghoshal, Kalpana, He, Xiaoming, Devine, Steven M., Zhang, Xiaoliu, Caligiuri, Michael A., Hofmeister, Craig C., Yu, Jianhua
Publicado 2013

Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2)

por Wood, William A., Dilip, Deepika, Derkach, Andriy, Grover, Natalie S., Elemento, Olivier, Levine, Ross, Thanarajasingam, Gita, Batsis, John A., Bailey, Charlotte, Kannappan, Arun, Devine, Steven M., Artz, Andrew S., Ligibel, Jennifer A., Basch, Ethan, Kent, Erin, Glass, Jacob
Publicado 2023

Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma

por Epperla, Narendranath, Ahn, Kwang Woo, Ahmed, Sairah, Jagasia, Madan, DiGilio, Alyssa, Devine, Steven M., Jaglowski, Samantha, Kennedy, Vanessa, Rezvani, Andrew R., Smith, Sonali M., Sureda, Anna, Fenske, Timothy S., Kharfan-Dabaja, Mohamed A., Armand, Phillipe, Hamadani, Mehdi
Publicado 2017

Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor

por Crees, Zachary D., Rettig, Michael P., Bashey, Asad, Devine, Steven M., Jaglowski, Samantha, Wan, Fei, Zhou, Amy, Harding, Melinda, Vainstein-Haras, Abi, Sorani, Ella, Gliko-Kabir, Irit, Grossman, Brenda J., Westervelt, Peter, DiPersio, John F., Uy, Geoffrey L.
Publicado 2023

Safety Profile of Good Manufacturing Practice Manufactured Interferon γ‐Primed Mesenchymal Stem/Stromal Cells for Clinical Trials

por Guess, Adam J., Daneault, Beth, Wang, Rongzhang, Bradbury, Hillary, La Perle, Krista M. D., Fitch, James, Hedrick, Sheri L., Hamelberg, Elizabeth, Astbury, Caroline, White, Peter, Overolt, Kathleen, Rangarajan, Hemalatha, Abu‐Arja, Rolla, Devine, Steven M., Otsuru, Satoru, Dominici, Massimo, O'Donnell, Lynn, Horwitz, Edwin M.
Publicado 2017

Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease

por Snyder, Katiri J., Choe, Hannah K., Gao, Yandi, Sell, Natalie E., Braunreiter, Kara M., Zitzer, Nina C., Neidemire-Colley, Lotus, Kalyan, Sonu, Dorrance, Adrienne M., Keller, Andrea, Mihaylova, Maria M., Singh, Satishkumar, Sehgal, Lalit, Bollag, Gideon, Ma, Yan, Powell, Ben, Devine, Steven M., Ranganathan, Parvathi
Publicado 2021

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS

por Nash, Richard A., Hutton, George J., Racke, Michael K., Popat, Uday, Devine, Steven M., Steinmiller, Kaitlyn C., Griffith, Linda M., Muraro, Paolo A., Openshaw, Harry, Sayre, Peter H., Stuve, Olaf, Arnold, Douglas L., Wener, Mark H., Georges, George E., Wundes, Annette, Kraft, George H., Bowen, James D.
Publicado 2017

A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485

por Mims, Alice S., Mishra, Anjali, Orwick, Shelley, Blachly, James, Klisovic, Rebecca B., Garzon, Ramiro, Walker, Alison R., Devine, Steven M., Walsh, Katherine J., Vasu, Sumithira, Whitman, Susan, Marcucci, Guido, Jones, Daniel, Heerema, Nyla A., Lozanski, Gerard, Caligiuri, Michael A., Bloomfield, Clara D., Byrd, John C., Piekarz, Richard, Grever, Michael R., Blum, William
Publicado 2018

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia

por Eapen, Mary, Zhang, Mei-Jie, Tang, Xiao-Ying, Lee, Stephanie J., Fei, Ming-Wei, Wang, Hai-lin, Hebert, Kyle M., Arora, Mukta, Chhabra, Saurabh, Devine, Steven M., Hamadani, Mehdi, D'Souza, Anita, Pasquini, Marcelo C., Phelan, Rachel, Rizzo, J. Douglas, Saber, Wael, Shaw, Bronwen E., Weisdorf, Daniel J, Horowitz, Mary M.
Publicado 2020